Aeterna Zentaris logo
Aeterna Zentaris AEZS

Annual report 2024
added 03-21-2026

report update icon

Aeterna Zentaris Long Term Debt Current 2011-2026 | AEZS

Annual Long Term Debt Current Aeterna Zentaris

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
271 K 299 K 114 K 130 K 135 K 648 K - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
648 K 114 K 266 K

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Amgen Amgen
AMGN
135 M $ 349.77 0.57 % $ 188 B usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
7.93 M $ 19.23 -1.38 % $ 899 M usaUSA
Altimmune Altimmune
ALT
256 K $ 3.44 2.99 % $ 303 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
5.05 M $ 1.4 2.19 % $ 357 M britainBritain
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.63 0.77 % $ 16.5 M usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
14.2 M $ 218.06 -1.72 % $ 5 B danmarkDanmark
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Benitec Biopharma Benitec Biopharma
BNTC
354 K $ 11.19 1.91 % $ 461 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
428 K - -10.17 % $ 12.2 K usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
768 K $ 2.09 - $ 195 M israelIsrael
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
440 K $ 0.61 -1.3 % $ 6.99 M israelIsrael
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Cellectis S.A. Cellectis S.A.
CLLS
7.7 M $ 3.42 2.4 % $ 116 M franceFrance
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Cullinan Management Cullinan Management
CGEM
780 K $ 12.84 0.78 % $ 774 M usaUSA
Atreca Atreca
BCEL
3.54 M - -11.76 % $ 5.79 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Calithera Biosciences Calithera Biosciences
CALA
1.37 M - -10.95 % $ 876 K usaUSA
CorMedix CorMedix
CRMD
853 K $ 6.42 2.72 % $ 462 K usaUSA
Cara Therapeutics Cara Therapeutics
CARA
1.92 M - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
2.81 M - - $ 3.74 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
203 K - -74.18 % $ 955 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Denali Therapeutics Denali Therapeutics
DNLI
8.31 M $ 21.09 4.56 % $ 3.47 B usaUSA
Dyadic International Dyadic International
DYAI
48.1 K $ 0.86 -8.51 % $ 24.8 M usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
425 K $ 4.42 4.25 % $ 734 M canadaCanada
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
410 K - 1.93 % $ 17.4 M usaUSA